Next Oncology - Houston

Houston, Texas 77055

8 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma of Esophagus, Advanced Metastatic Castration Resistant Prostate Cancer, Advanced Solid Tumor, Advanced Solid Tumors, Biliary Tract Carcinoma, Bladder Cancer, Endometrial Cancer, Gastric Adenocarcinoma, Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Gastroesophageal Cancer (GC), Mesothelioma, NSCLC (Non-small Cell Lung Cancer)

Studies at this site

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — Recruiting now
• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors — Recruiting now
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers — Recruiting now
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors — Recruiting now
• Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer — Recruiting now
• Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors — Recruiting now
• First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors — Starting soon